Sangamo Therapeutics Announces Q1 2024 Financial Results and ...

Sangamo Therapeutics Reports Strong Q3 2024 Growth - Nasdaq

Key financial highlights show a remarkable increase in revenue from $9.4 million to $49.4 million compared to the same period last year, ...

Sangamo Therapeutics, Inc. on LinkedIn: Our Q2 financial results ...

Our Q2 financial results will be announced on Tuesday, August 6, 2024, with a conference call at 4:30 PM ET ... Our 2024 Q1 financial results ...

Sangamo Therapeutics Announces Strategic Update and Reports ...

Revenues for the first quarter ended March 31, 2023, are estimated to be approximately $158.0 million, compared to $28.2 million for the same ...

News of SANGAMO THERAPEUTICS INC(NASDAQ:SGMO) stock

3 months ago - Sangamo Therapeutics, Inc. Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results. News Image. 3 ...

SGMO Q1-2024 Earnings Call - Alpha Spread

Sangamo Therapeutics Inc (NASDAQ:SGMO) Q1-2024 earnings call transcript ... This call includes forward-looking statements regarding Sangamo's current ...

Sangamo Therapeutics (SGMO) Earnings Date and Reports 2024

Quarterly revenue was reported to be $0.36 million, below analysts' expectations of $11.40 million. With a trailing EPS of -$0.75, Sangamo Therapeutics' ...

Sangamo Therapeutics Announces Strategic Update and Reports ...

Sangamo believes its cash, cash equivalents, and marketable securities as of September 30, 2023, in combination with the cost savings expected ...

Looking Ahead in Biopharma: 2024 - L.E.K. Consulting

Topline results Q1-2. PDUFA: April ... 33Press release, “Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results.

Sangamo Revenue Drops Due To Collaboration Endings

Sangamo Therapeutics Inc., a genomic medicine company, has reported business highlights and second quarter 2024 financial results. Revenues ...

SGMO SEC Filings - Sangamo Therapeutics, Inc.- Annual Report ...

Exhibit 99.1 Sangamo BioSciences Reports Third Quarter 2015 Financial Results Increases Year End Cash Guidance to Greater Than $200 Million RICHMOND, Calif., ...

Sangamo Therapeutics on X: "Our Q1 financial results will be ...

Our Q1 financial results will be announced on Thursday, May 9, 2024 at 4:30 PM ET. Details on how to join our conference call and webcast: ...

Sangamo Therapeutics's Earnings Outlook - Benzinga

Analysts expect Sangamo Therapeutics to report an earnings per share (EPS) of $-0.03. ... Q1 2024, Q4 2023, Q3 2023. EPS Estimate, -0.15, -0.21, - ...

ALGS - Aligos Therapeutics, Inc. Latest Stock News & Market Updates

What are the financial results for Aligos Therapeutics' first quarter 2024? ... For Q1 2024, Aligos reported a net loss of $34.9 million, with cash, cash ...

Sangamo Therapeutics (SGMO) earnings announcements and reports

Sangamo Therapeutics | 10-Q: Q2 2024 Earnings Report · Sangamo Therapeutics | 10-Q: Q1 2024 Earnings Report · Sangamo Therapeutics | 10-K: FY2023 Annual Report.

Sangamo Therapeutics Earnings Estimates - Moomoo

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement. Currency: USD. 2023/Q4 2024/Q1 2024/Q2 2024/Q3 ...

Sangamo Therapeutics - Recent News & Activity - Crunchbase

Yahoo Finance — Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained ... News• Nov 6, 2023.

Sangamo Therapeutics reports progress in gene therapies

However, the company is currently not profitable, with a negative P/E ratio of -2.88 over the last twelve months as of Q2 2024. This aligns with ...

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue ...

Sangamo Therapeutics ( SGMO Quick Quote SGMO - Free Report) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus ...

Sangamo Therapeutics Inc. Stock Quote (U.S. - SGMO - MarketWatch

SGMO | Complete Sangamo Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Sangamo Therapeutics, Inc. (SGMO) | News for ... - Options AI

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates. Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast. RICHMOND ...